Neurocrine Biosciences (NBIX) Income towards Parent Company (2010 - 2026)
Neurocrine Biosciences (NBIX) posted Income towards Parent Company of $144.4 million for Q2 2026, up 34.3% from $107.5 million a year earlier but down 27.0% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Income towards Parent Company (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Neurocrine Biosciences was $705.5 million, up 102.6% year-over-year; for FY2025, it was $478.6 million, up 40.2% from FY2024.
- Annual Income towards Parent Company has increased for four consecutive years, with a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Income towards Parent Company was $341.3 million in FY2024 (+36.7%), $249.7 million in FY2023 (+61.6%), $154.5 million in FY2022 (+72.4%) and $89.6 million in FY2021 (-78.0%).
- Quarterly Income towards Parent Company has run from a low of -$76.6 million in Q1 2023 to a high of $209.5 million in Q3 2025 over five years.
- On a year-over-year basis, Income towards Parent Company increased in five of the last seven quarters, with growth averaging 22.1%.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q3 2022, with growth of 204.4%; the weakest was Q1 2025, with a decline of 81.8%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $197.9 million (Q1 2026), $153.7 million (Q4 2025) and $209.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 144.40 Mn |
| Mar 31, 2026 | 197.90 Mn |
| Dec 31, 2025 | 153.70 Mn |
| Sep 30, 2025 | 209.50 Mn |
| Jun 30, 2025 | 107.50 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 103.10 Mn |
| Sep 30, 2024 | 129.80 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Mar 31, 2024 | 43.40 Mn |
| Dec 31, 2023 | 147.70 Mn |
| Sep 30, 2023 | 83.10 Mn |
| Jun 30, 2023 | 95.50 Mn |
| Mar 31, 2023 | -76.60 Mn |
| Dec 31, 2022 | 89.00 Mn |
| Sep 30, 2022 | 68.50 Mn |
| Jun 30, 2022 | -16.90 Mn |
| Mar 31, 2022 | 13.90 Mn |
| Dec 31, 2021 | -7.30 Mn |
| Sep 30, 2021 | 22.50 Mn |
API Access
Neurocrine Biosciences Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();